Raymond James Financial Services Advisors’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $11M | Sell |
|
|||||
|
2024
Q2 | $6.52M | Buy |
|
|||||
|
2024
Q1 | $1.72M | Buy |
|
|||||
|
2023
Q4 | $1.05M | Sell |
|
|||||
|
2023
Q3 | $890K | Buy |
|
|||||
|
2023
Q2 | $535K | Sell |
|
|||||
|
2023
Q1 | $522K | Sell |
|
|||||
|
2022
Q4 | $631K | Buy |
|
|||||
|
2022
Q3 | $357K | Sell |
|
|||||
|
2022
Q2 | $476K | Buy |
|
|||||
|
2022
Q1 | $246K | Sell |
|
|||||
|
2021
Q4 | $190K | Buy |
|
|||||
|
2021
Q3 | $123K | Buy |
|
|||||
|
2021
Q2 | $120K | Sell |
|
|||||
|
2021
Q1 | $133K | Buy |
|
|||||
|
2020
Q4 | $80K | Buy |
|
|||||
|
2020
Q3 | $95K | Sell |
|
|||||
|
2020
Q2 | $122K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $147K | Buy |
|
|||||
|
2018
Q2 | $67K | Buy |
|